Reproductive Factors and Risk of Breast Cancer by Tumor Subtypes among Ghanaian Women: A Population-based Case-control Study

Introduction

Reproductive factors have been well documented as key breast cancer risk factors with direct associations observed with early ages at menarche, nulliparity, late ages at first birth and limited breastfeeding. Breast cancer is a heterogeneous disease, with differential etiologic associations for tumor subtypes defined by estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status.(1) Most of these results derive from studies on European ancestry populations. Similar investigations among African ancestry populations are crucial given the differences in demographic and risk factor distributions and their disproportionately high incidence of early-onset breast cancer and ER-negative aggressive subtypes.(1-4)

Analyses of risk factors by the African American Breast Cancer Epidemiology and Risk (AMBER) consortium have revealed differential risk factor associations by tumor subtypes defined by ER, PR, and HER2 status.(5,6) Parity was associated with a decreased risk for ER-positive cancers but an increased risk for triple-negative breast tumors; furthermore, ever breastfeeding in parous women was strongly inversely related to the risk of triple-negative tumors.(6) Accumulating data support similar observations in other studies on women of African American and European ancestry, although distributions of risk factors differ.(1,7-11)

With substantially increasing rates of breast cancer in sub-Saharan Africa, identifying risk factors and strategies for reducing incidence are essential.(12,13) A population-based case-control study of breast cancer in Ghana aimed to overcome challenges of previous African studies that were unable to select population-based controls and properly classify hormone receptor-negative cases.(3,12,14,15) Using a census-based sampling of controls (16) and standardized protocols for collecting tumor biopsy samples for immunohistochemical (IHC) staining from cases prior to treatment (17), we sought to determine the associations between menstrual and reproductive risk factors and breast cancer subtypes.

Methods

See Supplemental Material for further details on methods for study population, risk factor information, ethical approvals, tumor characteristics, and statistical analysis.

Results

Descriptive characteristics of cases and controls

Cases were slightly older than controls reflecting that the controls were initially frequency matched to all women with a suspicion of breast cancer prior to diagnosis confirmation. Approximately half of these women had non-malignant breast diseases and tended to be younger than those with malignant breast disease.(17) The cases more often than the controls reported late ages at menarche, few births, late ages at first birth and low median breastfeeding months (Table 1).

View this table:

• View inline
• View popup

Table 1. Demographic and reproductive characteristics of 1,126 diagnosed invasive breast cancer cases and 2,106 controls from the Ghana Breast Health Study

A total of 50%, 52% and 23% of cases were ER positive, PR positive, and HER2 positive, respectively (Table 1). Luminal A-like breast cancer was the most common subtype (49%) followed by triple-negative/basal-like (28%), HER2-enriched (15%) and luminal B-like breast cancers (8%) (Fig. 1). There were no significant differences in cases missing ER, PR and HER2 status by risk factor data (data not shown).

• Download figure
• Open in new tab

Fig. 1: Details of cases and controls for analysis of reproductive factors and breast cancer risk by tumor characteristics in the Ghana Breast Health Study

Intrinsic-like subtype distribution for cases with immunohistochemical data on ER, PR, and HER2 defined as luminal A-like (ER+ or PR+ and HER2−), luminal B-like (ER+ or PR+ and HER2+), HER2-enriched-like (ER− or PR− and HER2+), or triple-negative/basal-like (ER−, PR− and HER2−).

We assessed descriptively if reproductive factors varied by birth cohort (1945–1975), which are presented in Fig. 2. Number of births was lower in later birth cohorts compared to earlier birth cohorts, with cases having fewer births on average compared with the controls (1945, mean 4.1 for cases and 6.4 for controls; 1975, mean 2.5 for cases and 3.3 for controls). Age at first birth increased by approximately 1 year in the later compared with earlier birth cohorts for both cases and controls (21.7 in 1945 and 22.3 in 1975 among controls). Age at menarche showed no apparent trends, hovering around 15 years across the birth cohorts. Breastfeeding months per pregnancy among controls declined until the 1960s and steadily increased until 1975. Among the cases, breastfeeding months per pregnancy increased over time by 1 month per pregnancy from 17 to 18 months.

• Download figure
• Open in new tab

Fig. 2: Temporal trends of menstrual and reproductive risk factors for cases and controls in the Ghana Breast Health Study by birth cohorts from 1945 to 1975

(A) Age at menarche, (B) parity, (C) age at first birth and (D) median breastfeeding months per pregnancy. The means and standard deviations plotted are the results of a 3-point running average. Gray indicates standard deviation.

Associations with reproductive factors by ER and stratified by age

Analyses for all cases combined did not show statistically significant differences for ER-negative compared with ER-positive cases (Supplementary Table 2). When we evaluated the associations by ER status among women aged <50 years (Table 3), we observed a strong inverse association with parity for ER-positive tumors and a positive association for ER-negative tumors, with the test for heterogeneity being statistically significant (P-het = 0.02). Among women <50 years, older ages at first birth showed a slightly stronger association with increased risk for ER-positive than ER-negative breast tumors, but the test for heterogeneity was not statistically significant. Extended breastfeeding only showed an inverse association among ER-negative tumors, with evidence of significant heterogeneity compared with ER-positive tumors (≥19 vs <13 months: ER-positive tumors OR 1.39, 95% CI 0.82–2.34; ER-negative tumors 0.71, 0.45–1.12; P-het = 0.04). There was no additional relationship for ≥19 breastfeeding months; when we compared women with ≥13 breastfeeding months per pregnancy to <13 months, the resultant OR for ER-negative tumors was OR 0.69 (95% CI 0.45–1.03). There was a suggestion of a positive association with older ages at menarche for ER-positive breast tumors that was not apparent for ER-negative breast tumors.

View this table:

• View inline
• View popup
• Download powerpoint

Table 3. Reproductive risk factors and breast cancer risk stratified by ER status among women <50 years of age among 378 cases and 1,294 controls

Among the women aged ≥50 years (Table 4), parity was inversely associated with risk for both ER-negative and ER-positive tumors (although there were few nulliparous women, p-het = 0.33). Although extended breastfeeding showed an inverse association regardless of ER status, a stronger association was observed among ER-positive tumors (P-het = 0.07). Age at first birth did not demonstrate any consistent associations with risk.

View this table:

• View inline
• View popup
• Download powerpoint

Table 4. Risk factor associations stratified by ER status among women ≥50 years of age among 398 cases and 802 controls

We further assessed the joint effects of parity and breastfeeding per pregnancy (Fig. 3). Among women aged ≥50 years, increasing parity, and breastfeeding were associated with reduced risks for both ER-negative and ER-positive tumors, with the lowest risks observed among women with ≥3 births who breastfed for ≥13 months/pregnancy compared with nulliparous women (ER-negative cases: OR 0.45, 95% CI 0.21–0.95; ER-positive cases: OR 0.31, 95% CI 0.13–0.75). This trend was less apparent among women aged <50 years with ER-positive tumors [≥3 births who breastfed for ≥13 months/pregnancy compared with nulliparous women (OR 0.69, 95% CI 0.36–1.30)]. In contrast, among women aged <50 years with ER-negative tumors, compared with nulliparous women, the highest risk was for those with ≥3 births who breastfed <13 months/pregnancy (OR 1.91, 95% CI 0.89–4.10).Women with ≥3 births who breastfed, on average, ≥13 months per pregnancy were not at increased risk (OR 1.09, 95% CI 0.56–2.10), due to the multiplicative joint association of two factors associated with risk in opposite directions.

• Download figure
• Open in new tab

Fig. 3: ORs and 95% CIs for joint effects of parity and breastfeeding (vs nulliparous) by ER status and age of onset

Polytomous logistic regression models were used to calculate ORs and 95% CI, adjusted for age, education, study site, body size, family history of breast cancer, age at menarche, age at first birth, menopausal status, and age at menopause. Error bars indicate standard deviations = breastfeeding. ER = Estrogen receptor.

Discussion

Among Ghanaian women, we observed substantial heterogeneity of the parity association with breast cancer risk by age at diagnosis and ER status, with strong inverse associations for all tumor subtypes in older (≥50 years) women and for younger-onset ER-positive tumors, but an opposite association for younger-onset ER-negative tumors (i.e. increased risk with increasing birth numbers). Median breastfeeding months per pregnancy was strongly inversely associated with later-onset breast tumor risk (particularly ER-positive or luminal A-like tumors); among younger women, it was an apparent protective factor for ER-negative tumors only. Similar to previous reports,(6-9,20,21) our study population allowed an evaluation of associations for a wide range of number of births and breastfeeding months per pregnancy.

Few studies have addressed the relation of reproductive risk factors in women of African ancestry. The largest dataset derives from the African Breast Cancer Study (ABCS),(22) a hospital-based case-control study in Nigeria, Cameroon and Uganda, comprising 1,995 cases and 2,631 controls (with 81% of the cases from Nigeria). Analyses from this study showed changing reproductive patterns over time (particularly number of births) and an inverse association of risk with parity; however, it did not show statistically significant heterogeneity of risk associations by menopausal status or age at diagnosis.(22,23) Notably, in contrast to our study, ABCS was not population-based and lacked information on hormone receptor status of the tumors, thereby limiting the comparability of the findings. Data from the AMBER consortium, a pooled analysis of four studies of African-American women with available tumor IHC data found that among 1,252 ER-negative breast tumors parous women were at elevated risk compared with nulliparous women, increasing to 1.60 among those aged <40 years.(6) Our data are consistent with AMBER and other recent studies,(9,11) supporting a cross-over association between parity on breast cancer risk that is dependent on age at onset and ER status.

In our Ghanaian population, number of births and breastfeeding years were highly correlated. Our data showed a significant inverse risk relationship with median breastfeeding months per pregnancy, with a 15% reduced risk for those with 13–18 vs <13 months/pregnancy. In pooled analyses of populations of European ancestry, breastfeeding has been shown to have a weak inverse association with breast cancer risk. However, recent data that includes molecular subtyping information provides evidence of a possible stronger inverse association for hormone-negative breast tumors.(6-9,20,21) In the AMBER study, the inverse association of breastfeeding was most pronounced for younger-onset ER-negative and triple-negative breast tumors. In fact, for such tumors, analyses demonstrated that extended breastfeeding could reduce the adverse risks associated with parity, which has also been seen in other studies that included African-American women.(9,11) Our results revealed similar associations given that extended breastfeeding appeared to largely counteract the adverse relationship with multiparity among younger women with ER-negative tumors.

Recent studies assessing associations by molecular subtypes using IHC and mRNA expression profiling have shown increased risk with parity that may predominate for triple-negative or basal-like breast tumors.(20,24) In our study, the modifications in risk associations between parity and breastfeeding by age reflected different temporal trend patterns by birth cohorts in cases and controls: the rate of decrease in number of births was faster for controls than cases in early birth cohorts (i.e., older women); a decreasing trend of breastfeeding months per pregnancy in early birth cohorts was seen in controls but not in cases. Given that multiparity and increased breastfeeding are inversely associated with later-onset breast cancers (with somewhat stronger associations with ER-positive tumors), if the observed temporal trends of decreasing parity and breastfeeding continue, they are likely to result in an increased incidence of later-onset breast cancer.(13) This indicates the importance of public health measures to maintain high rates of breastfeeding,(25) which could potentially attenuate the projected increase in risk due to changes in reproductive patterns and demographics.(13,26)

Older age at first birth has been associated with increases in breast cancer risk in numerous studies, particularly for ER-positive tumors.(8,10,20,27,28) The AMBER consortium also found increased risks for older ages at first birth for ER-positive but not for ER-negative tumors. Our data were consistent with these findings, suggesting that this association may be stronger or limited to early-onset ER-positive breast cancer cases.(6) However, in African populations, this is a difficult exposure to assess given that few women actually delay their first births until truly late ages. With increasing adoption of westernized lifestyles and access to birth control, continued monitoring of maternity data are needed to determine if ages at first birth continue to increase.

In spite of the observed trends in reproductive patterns toward westernization, our study population still maintained higher parity and breastfeeding frequencies compared with other populations. The reproductive patterns in our study are consistent with recent nationally representative surveys.(29,30) For example, the decline in fertility rate from 6.4 in 1988 to 3.9 in 2017 reported in surveys by the Ghana Maternal Health Survey ages 15–49 years is similar to the decline in average number of live births in our control population from 6.4 to 3.3 for women born in 1945 (i.e. 43 years old in 1988) and 1975 (i.e. 42 years old in 2017).(29) Median breastfeeding months per pregnancy were 17 to 18 months in our study controls and in a 2011 survey median months breastfeeding were 17.4 and 17.9 months for Greater Accra and Ashanti regions, respectively.(30) The strong inverse associations of these factors with late onset, mostly ER-positive tumors, together with a lack of population-based screening, are likely important factors contributing to historically low incidence of late onset ER-positive breast cancers. In contrast, for early-onset cancers, higher parity was directly associated with ER-negative disease in our study. It is doubtful, however, that high parity explains the higher incidence of ER-negative early-onset cancers in our population given the high prevalence of breastfeeding, which appeared to offset the higher risk from multiparity. Instead, the younger demographics in Ghana and other sub-Saharan African countries probably explains the higher proportion of these early-onset cancers compared with populations of European ancestry.(3) It may be that rather than a population with an “excess” of early-onset ER-negative cancers that there could be fewer diagnoses of late onset ER-positive breast cancer compared with other populations, as suggested in other studies.(31) To specifically address this, further studies comparing age-incidence rates of breast cancer subtypes in Africa are needed, similar to U.S. studies that have addressed racial differences by age.(32)

Age at menarche has been inversely associated with risk in European ancestry populations.(33) In the studies of African-American women, later ages at menarche were inversely associated with breast cancer regardless of hormone receptor status.(5,9) In contrast, we observed no such relationship. The median age of menarche of 15 years in Ghanaian women is quite different from the reported age of 12 years among African-American women, with our study having limited variation in ages at menarche. Increased nutrition has been suggested to lower the age at menarche; this variable could reflect early exposures that may differ between populations (e.g. early adolescent weight).(34) In addition, a substantial number of women in our study could not recall their ages at menarche, suggesting that measurement error could have impacted our ability to assess relationships reliably.

Strengths of this study are the population-based design, detailed risk factor assessment, and tissue collection for quality assessment of IHC markers to examine etiologic heterogeneity in sub-Saharan Africa. A limitation is that although IHC data can be used as a proxy for molecular subtypes, mRNA expression assays are required to classify previously described intrinsic molecular subtypes, especially HER2-enriched and luminal B subtypes. Further, although our study is one of the largest breast cancer epidemiological studies conducted in sub-Saharan Africa, analyses by age and subtypes resulted in small numbers within strata of these critical factors.

Our study indicates that while reproductive factors showed important temporal trends and distinct distributions compared with African-American or European ancestry populations, their associations with breast cancer risk were generally consistent with those observed in these populations. Our data support the importance of breastfeeding to prevent early-onset ER-negative breast cancer associated with multiparty and the longer-term protection of parity and breastfeeding for later-onset breast tumors, irrespective of their ER status. Further studies including more detailed molecular characterization of tumors and additional risk factors may provide additional insights into breast cancer etiology in sub-Saharan Africa.

Funding

This work was supported by Intramural program of the National Cancer Institute.

Author contributions

Conception & Design of the study: JDF, BDL, LE, NT, EA, JNCL, JY, BW, BA, MD, SW, KN, FA, DA, SH, TA, MGC, LAB; Data collection: JDF, BDL, LE, NT, EA, JNCL, JY, BW, BA, MD, SW, KN, FA, DA, SH, TA, MGC, LAB; Interpretation of data JDF, BDL, LE, NT, EA, JNCL, JY, BW, BA, MD, SW, KN, FA, DA, SH, TA, MGC, LAB; Drafting of the manuscript: JDF, BDL, LAB, MGC; Revised work and provided important intellectual content: JDF, BDL, LE, NT, EA, JNCL, JY, BW, BA, MD, SW, KN, FA, DA, SH, TA, MGC, LAB.

Conflict of Interest

none declared

Ghana Breast Health Study team

Ghana Statistical Service, Accra, Ghana: Dr Robertson Adjei and Dr Lucy Afriyie. Korle Bu Teaching Hospital, Accra, Ghana: Dr Anthony Adjei, Dr Florence Dedey, Dr Verna Vanderpuye, Victoria Okyne, Naomi Ohene Oti, Evelyn Tay, Dr Adu-Aryee, Angela Kenu and Obed Ekpedzor. Komfo Anoyke Teaching Hospital, Kumasi, Ghana: Marion Alcpaloo, Isaac Boakye, Bernard Arhin, Emmanuel Assimah, Samuel Ka-chungu, Dr Joseph Oppong and Dr Ernest Osei-Bonsu. Peace and Love Hospital, Kumasi, Ghana: Prof Margaret Frempong, Emma Brew Abaidoo, Bridget Nortey Mensah, Samuel Amanama, Prince Agyapong, Debora Boateng, Ansong Thomas Agyei, Richard Opoku and Kofi Owusu Gyimah. Memorial Sloan Kettering Cancer Center, NY, USA: Dr Lisa Newman. National Cancer Institute, Bethesda, MD, USA: Maya Palakal and Jake Thistle. Westat, Inc.: Michelle Brotzman, Shelley Niwa, Usha Singh and Ann Truelove. University of Ghana: Prof Richard Biritwum.